Monitor the actual investor presentation on Virax's IR website for any forward-looking statements or pipeline catalysts that could move the stock. Given the tiny market cap, even speculative updates can trigger volatility, but this filing alone offers no actionable signal.
Price Chart
Executive Summary
Virax Biolabs published an updated Q3 2026 investor presentation on its IR website, which is filed via Form 6-K. The filing itself contains no financial results, guidance, or material operational updates — it is a routine disclosure of a corporate presentation.
Key Facts
- Filed on August 18, 2026, as a Form 6-K for Virax Biolabs Group Ltd (VRAX).
- Discloses the publication of an 'updated Q3 2026 investor presentation' on the company's IR website.
- No financial figures, guidance changes, or material corporate events are referenced in the filing document.
- Company is a micro-cap diagnostic substances firm with a $2M market cap and high analyst bullish consensus (86% buy/strong buy).
Financial Impact
No financial data provided in the filing; investor presentation content was not included in the document set.
Risk Factors
- Investor presentation content may contain no material new information, leading to no price reaction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-354722 |
| Document: 0001193125-26-354722-index-headers.html | 0001193125-26-354722 |
| Document: 0001193125-26-354722-index.html | 0001193125-26-354722 |
| Document: 0001193125-26-354722.txt | 0001193125-26-354722 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 16d ago | 6-K | $1.85 | awaiting T+20 | — | $1.23 (−33.51%) |
Sep 4, 2026 7w ago | 6-K | $2.63 $2.03 | ▲ +22.81% | ▲ +24.53% | $1.23 (+53.23%) |
Sep 4, 2026 7w ago | EFFECT | $2.63 $2.40 | ▼ −8.57% | ▼ −9.17% | $1.23 (−53.14%) |
Aug 18, 2026 9w ago | 6-K | $2.76 $2.45 | ▼ −11.20% | ▼ −10.21% | $1.23 (−55.43%) |
Jul 31, 2026 12w ago | 6-K | $2.62 $2.82 | ▼ −7.63% | ▼ −4.65% | $1.23 (+53.05%) |
Jul 16, 2026 14w ago | 6-K | $3.90 $2.82 | ▼ −27.69% | ▼ −31.31% | $1.23 (−68.46%) |
Jul 9, 2026 15w ago | Press Release | $6.36 $2.77 | ▲ +56.45% | ▲ +58.69% | $1.23 (+80.66%) |
Jul 9, 2026 15w ago | 6-K | $6.36 $2.77 | ▼ −56.45% | ▼ −58.69% | $1.23 (−80.66%) |
Jun 24, 2026 17w ago | 6-K | $0.1350 $0.1276 | ▼ −5.48% | ▼ −6.11% | $1.23 (+811.11%) |
Jun 12, 2026 19w ago | 6-K | $0.1840 $0.1496 | ▼ −18.70% | ▼ −20.05% | $1.23 (+568.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers